Solana (HSDT) Financials

Solana (NASDAQ:HSDT) remains in a transition phase. The latest statements show a sharp improvement in revenue from the very low levels reported during 2024 and early 2025, but the company is still generating substantial operating losses and consuming cash. The data also includes several restated periods and unusually large noncash items, so investors should focus on recurring revenue, operating cash flow and funding needs rather than headline net income alone.

• Revenue has improved materially. Q2 2026 revenue reached $2.5 million, up from $43,000 in Q2 2025 and $182,000 in Q2 2024. Revenue also increased from $697,000 in Q3 2025, although it declined sequentially from $3.6 million in Q1 2026.
• Gross margins are currently strong. Q2 2026 gross profit was $2.4 million, representing approximately 97% of revenue. This compares with negative gross profit in Q2 2025 and Q3 2025, indicating that recent revenue growth has been achieved with relatively low reported cost of revenue.
• Quarterly losses narrowed sequentially. The net loss improved to $30.3 million in Q2 2026 from a $99.8 million loss in Q1 2026. The improvement was primarily due to lower operating expenses and a $2.4 million gain in other income.
• The balance sheet has a substantial equity cushion on paper. At June 30, 2026, total equity was $165.6 million versus total liabilities of $6.4 million. Current assets of $28.7 million also exceeded current liabilities of $2.2 million by a wide margin.
• Recent financing provided additional liquidity. The company issued $8.0 million of common equity during Q2 2026, partially offsetting $2.3 million of share repurchases. This helped limit the quarterly decline in cash despite negative operating cash flow.

• Reported assets have changed dramatically. Total assets rose from $8.9 million in Q3 2023 to $475.9 million in Q3 2025, then declined to $176.1 million by Q2 2026. Much of the movement occurred in “other noncurrent operating assets,” making it difficult to assess the quality and recoverability of the company’s asset base from the standardized data alone.
• Q4 2025 profitability was not representative of ongoing operations. The company reported $325.6 million of net income in that quarter, but operating income was negative $201.1 million and other income was $526.6 million. The result appears to have been driven primarily by a large non-operating gain rather than recurring business performance.

• Operating losses remain severe. Q2 2026 operating expenses totaled $35.1 million against $2.5 million of revenue, producing an operating loss of $32.7 million. Selling, general and administrative expense was $11.1 million, while other operating expenses were $24.0 million.
• Operating cash flow has remained negative throughout the reported periods. Net cash used in operations was $11.9 million in Q2 2026, following outflows of $4.8 million in Q1 2026, $6.2 million in Q4 2025 and $4.0 million in Q3 2025. This indicates that the business is not yet funding itself through operations.
• Cash reserves have fallen sharply. Cash declined from $124.1 million at September 30, 2025, to $3.6 million at June 30, 2026. Although the latest balance sheet reports significant noncurrent assets, the company’s immediately available cash is relatively limited compared with its quarterly operating cash burn.
• The company remains dependent on equity financing. Common-stock issuance was $403.9 million in Q3 2025, $50.0 million in Q4 2025 and $8.0 million in Q2 2026. Repeated reliance on equity raises can dilute existing shareholders and may indicate that additional capital will be required if operating losses continue.
• Retained earnings remain deeply negative. Retained earnings were negative $342.6 million at June 30, 2026, reflecting the cumulative impact of prior losses. The company’s reported equity is supported largely by contributed capital rather than accumulated profits.
• Share-count comparisons are difficult and dilution risk is significant. Weighted-average basic shares increased from 123,335 in the restated Q2 2025 data to 79.8 million in Q2 2026. Reverse splits, recapitalizations or other capital-structure changes may affect per-share comparisons, while future equity financing could further dilute shareholders.

Overall, the financial statements show encouraging revenue expansion and strong reported gross margins, but the investment case remains highly speculative. Sustainable improvement would require substantially lower operating expenses, positive operating cash flow and less dependence on new equity financing.